Letter to Mark Trudeau, President and Chief Executive Officer of Mallinckrodt Pharmaceuticals - Greg Walden Presses Opioid Manufacturers About Their Role in Crisis
Letter
Date: Aug. 2, 2018
Location: Washington, DC
Issues: Drugs